These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 36636955)

  • 1. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
    Bonazzetti C; Tazza B; Gibertoni D; Pasquini Z; Caroccia N; Fanì F; Fornaro G; Pascale R; Rinaldi M; Miani B; Gamberini C; Morelli MC; Tamé M; Busutti M; Comai G; Potena L; Borgese L; Salvaterra E; Lazzarotto T; Scudeller L; Viale P; Giannella M;
    Clin Infect Dis; 2023 May; 76(10):1761-1767. PubMed ID: 36636955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral antibody response following mRNA vaccines against SARS-CoV-2 in solid organ transplant recipients; a status after a fifth and bivalent vaccine dose.
    Christophorou E; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Pedersen RM; Justesen US; Johansen NE; Bistrup C; Madsen LW; Johansen IS
    Front Immunol; 2023; 14():1270814. PubMed ID: 38090591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
    Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
    Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort.
    Giannella M; Huth M; Righi E; Hasenauer J; Marconi L; Konnova A; Gupta A; Hotterbeekx A; Berkell M; Palacios-Baena ZR; Morelli MC; Tamè M; Busutti M; Potena L; Salvaterra E; ; Feltrin G; Gerosa G; Furian L; Burra P; Piano S; Cillo U; Cananzi M; Loy M; Zaza G; Onorati F; Carraro A; Gastaldon F; Nordio M; Kumar-Singh S; Baño JR; Lazzarotto T; Viale P; Tacconelli E
    Clin Microbiol Infect; 2023 Aug; 29(8):1084.e1-1084.e7. PubMed ID: 37150358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.
    Tsoutsoura P; Xagas E; Roussos S; Hatzakis A; Gourzi P; Boletis IN; Marinaki S
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374279
    [No Abstract]   [Full Text] [Related]  

  • 6. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
    Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
    Front Immunol; 2022; 13():832501. PubMed ID: 35281023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.
    Yanis A; Haddadin Z; Spieker AJ; Waqfi D; Rankin DA; Talj R; Thomas L; Birdwell KA; Ezzell L; Blair M; Eason J; Varjabedian R; Warren CM; Nochowicz CH; Olson EC; Simmons JD; Yoder S; Guy M; Thomsen I; Chappell JD; Kalams SA; Halasa NB
    Transpl Infect Dis; 2022 Feb; 24(1):e13772. PubMed ID: 34905653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective study.
    Yoshikawa M; Natori Y; Oki R; Unagami K; Ohfuji S; Imamura R; Ishida H; Takahara S; Hirota Y; Egawa H
    Scand J Immunol; 2023 Oct; 98(4):e13308. PubMed ID: 38441221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
    Yang J; Lee KW; Baek JY; Bae S; Lee YH; Kim H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR; Park JB; Kim SH; Kim TJ; Kim DM; Ko JH
    Am J Transplant; 2023 Apr; 23(4):565-572. PubMed ID: 36739177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients.
    Sakuraba A; Luna A; Micic D
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological findings following the second and third SARS-CoV-2 vaccines in lung transplant recipients.
    Bárczi E; Varga V; Nagy A; Eszes N; Jáky-Kováts Z; Müller V; Bohács A
    Immun Inflamm Dis; 2022 Aug; 10(8):e646. PubMed ID: 35894705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
    Vanlerberghe B; Vrij C; Bogaerts K; Vermeersch P; Lagrou K; Molenberghs G; Rega F; Ceulemans LJ; van Raemdonck D; Jochmans I; Monbaliu D; Pirenne J; Vanuytsel T; Gillard P; Schoemans H; Cleemput JV; Kuypers D; Vos R; Nevens F; Verbeek J
    J Med Virol; 2023 Apr; 95(4):e28736. PubMed ID: 37185854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.
    Verleye A; Wijtvliet V; Abrams S; Hellemans R; Bougrea R; Massart A; Pipeleers L; Wissing KM; Ariën KK; De Winter BY; Van Damme P; Abramowicz D; Ledeganck KJ
    Nephrol Dial Transplant; 2022 Jul; 37(8):1566-1575. PubMed ID: 35544087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
    Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
    Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients.
    Callaghan CJ; Mumford L; Curtis RMK; Williams SV; Whitaker H; Andrews N; Lopez Bernal J; Ushiro-Lumb I; Pettigrew GJ; Thorburn D; Forsythe JLR; Ravanan R;
    Transplantation; 2022 Mar; 106(3):436-446. PubMed ID: 34982758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-spike antibody durability after SARS-CoV-2 vaccination in adolescent solid organ transplant recipients.
    McAteer J; Kalluri DD; Abedon RR; Qin CX; Auerbach SR; Charnaya O; Danziger-Isakov LA; Ebel NH; Feldman AG; Hsu EK; Mohammad S; Perito ER; Thomas AM; Chiang TPY; Garonzik-Wang JM; Segev DL; Werbel WA; Mogul DB
    Pediatr Transplant; 2024 Feb; 28(1):e14671. PubMed ID: 38317335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients.
    Natori Y; Martin E; Mattiazzi A; Arosemena L; Ortigosa-Goggins M; Shobana S; Roth D; Kupin WL; Burke GW; Ciancio G; Morsi M; Phancao A; Munagala MR; Butrous H; Manickavel S; Sinha N; Sota K; Pallikkuth S; Bini J; Simkins J; Anjan S; Vianna RM; Guerra G
    Transpl Int; 2023; 36():10938. PubMed ID: 37091963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection.
    Goda Y; Nakajima D; Tanaka S; Yamada Y; Yutaka Y; Unagami K; Yoshikawa M; Egawa H; Date H
    Gen Thorac Cardiovasc Surg; 2023 Apr; 71(4):251-257. PubMed ID: 36289168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection.
    Rezahosseini O; Hamm SR; Heftdal LD; Pérez-Alós L; Møller DL; Perch M; Madsen JR; Hald A; Hansen CB; Armenteros JJA; Pries-Heje MM; Hasselbalch RB; Fogh K; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Iversen K; Bundgaard H; Sørensen SS; Rasmussen A; Garred P; Nielsen SD
    Front Immunol; 2022; 13():1075423. PubMed ID: 36713395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.